G211-0271 Screening compound: 2-cyclohexyl-N-[2-(2,5-dimethoxyphenyl)ethyl]-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

G211-0271 Screening compound: 2-cyclohexyl-N-[2-(2,5-dimethoxyphenyl)ethyl]-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide
G211-0271 Screening compound: 2-cyclohexyl-N-[2-(2,5-dimethoxyphenyl)ethyl]-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G211-0271
2-cyclohexyl-N-[2-(2,5-dimethoxyphenyl)ethyl]-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G211-0271

Molecular Formula

C28H31N3O4 (C28 H31 N3 O4)

Compound Name

2-cyclohexyl-N-[2-(2,5-dimethoxyphenyl)ethyl]-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

IUPAC name

2-cyclohexyl-N-[2-(25-dimethoxyphenyl)ethyl]-3-oxo-1H2H3H-pyrrolo[34-b]quinoline-9-carboxamide

SMILES

COc(cc1)cc(CCNC(c2c(CN(C3CCCCC3)C3=O)c3nc3ccccc23)=O)c1OC

InChI

InChI=1S/C28H31N3O4/c1-34-20-12-13-24(35-2)18(16-20)14-15-29-27(32)25-21-10-6-7-11-23(21)30-26-22(25)17-31(28(26)33)19-8-4-3-5-9-19/h6-7,10-13,16,19H,3-5,8-9,14-15,17H2,1-2H3,(H,29,32)

InChI Key

GEYNAWAMRYSSBG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27210927

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.640

Distribution Coefficient, logD

4.640

Water Solubility, LogSw

-4.61

Polar Surface Area

64.893

Acid Dissociation Constant (pKa)

12.55

Base Dissociation Constant (pKb)

6.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.30

G211-0271 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GABA Library (7115 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G211-0271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G211-0271?
Check Price and Availability of G211-0271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G211-0271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G211-0271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G211-0271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G211-0271 available by request